Wang Qun
Wang Qun — Chief Physician — Thoracic Surgery — Zhongshan Hospital affiliated with Fudan University
Specialties
Proficient in the diagnosis and treatment of various common and rare diseases in general thoracic surgery, with extensive clinical experience in both routine and complex thoracic surgical procedures, advocating standardized treatment for lung cancer and esophageal cancer. Skilled in various minimally invasive thoracic surgeries, including total thoracoscopic lobectomy, segmentectomy, thoracoscopic total thymectomy, thoracoscopic surgery for benign esophageal diseases, and esophageal cancer.
Education
Doctor
Professional Experience
PhD, Chief Physician, Head of Thoracic Surgery at Zhongshan Hospital Affiliated to Fudan University, and Doctoral Supervisor. Studied at UMASS Medical Center in the United States in 2000. Currently serves as a member of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association, Deputy Director of the Thoracic Surgery Branch of the Shanghai Medical Association, Standing Committee Member of the Thoracic Surgery Branch of the Chinese Medical Doctor Association (Deputy Director of the Shanghai Work Department), Fellow (FRCS, Fellow of the Royal College of Surgeons) in the UK, Standing Committee Member of the Esophageal Cancer Professional Committee of the Chinese Anti-Cancer Association, Member of the Lung Cancer Professional Committee of the Chinese Anti-Cancer Association, Standing Committee Member of the Thoracic and Cardiac Surgery Branch of the Ministry of Health Endoscopy Professional Technical Evaluation Committee, Deputy Director of the Thoracic Tumor Professional Committee of the Shanghai Anti-Cancer Association, Deputy Leader of the Thoracoscopy Group of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association, Member of the Esophageal Disease Group of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association, Member of the Lung Cancer Group of the Chinese Medical Association Thoracic and Cardiovascular Surgery Branch, Director of the International Chinese Thoracic Surgery Society, Member of the Oncology Nutrition Group of the Parenteral and Enteral Nutrition Branch of the Chinese Medical Association, Member of the Thoracic Surgery Expert Group of the Ministry of Health Clinical Pathway Expert Committee, Editorial Board Member of the Chinese Journal of Thoracic and Cardiovascular Surgery, Corresponding Editorial Board Member of the Chinese Journal of Gastrointestinal Surgery, Associate Editor of the Journal of Thoracic Disease Endoscopy, Editorial Board Member of the Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, and Editorial Board Member of the Shanghai Medical Journal. He is proficient in the diagnosis and treatment of various common and rare diseases in general thoracic surgery, with rich clinical experience in both routine and complex thoracic surgeries, especially in lung cancer, esophageal cancer, and other conditions. He advocates standardized treatment for lung and esophageal cancers, with particular emphasis on thorough lymph node dissection during lung and esophageal cancer surgeries. He specializes in various minimally invasive surgeries such as VATS lobectomy. In research, as the second applicant, he participated in the Shanghai Mountaineering Program project "Prospective Multicenter Study on Minimally Invasive Surgical Treatment of Early Non-Small Cell Lung Cancer," and as a key participant in the National National Eleventh National Festival. Fifth Program project "Phase III, randomized, open-label, multicenter clinical study comparing adjuvant NP combined with Endu regimen for stage IB-IIIA NSCLC with NP alone," participated as first collaborator in the "985" Phase III project "Cancer Metastasis Research and Its Clinical Translation" in "Lung Cancer Metastasis Research"; as first collaborator, participated as the first in the 2010 Ministry of Health affiliated hospital clinical discipline key project "Optimization and Application Promotion of Comprehensive Lobectomy for Early Non-Small Cell Lung Cancer"; as subproject leader in the 2012 "863" project "Application Research of Minimally Invasive Techniques in Thoracic and Cardiac Surgery." Principal investigator of the Shanghai Natural Science Foundation project (14ZR1406000): Study on the regulatory effect of the JAK/STAT pathway on TRPC6 expression in tumors.
Professional Roles
Member of the Chinese Medical Association